SENSEX NIFTY
Nov 22, 2012, 04.12 PM IST | Source: CNBC-TV18

Cipla can touch Rs 462: Mehta

Devang Mehta, Anand Rathi Financial Services is of the view that investor can hold Cipla with a target of Rs 462.

Devang Mehta

Vice President & Head - Equity Sales

Expertise : Equity - Technical

More about the Expert...

Devang Mehta, Anand Rathi Financial Services is of the view that investor can hold Cipla with a target of Rs 462.

Mehta told CNBC-TV18 the pricing policy ( more details ) was overall fair to neutral for the pharma sector and may not have impact on Cipla as such. However, he says, Cipla acquisition of South Africa's Cipla Medpro is going to augur well for the Indian pharma major. “It is going to be earnings accretive (earnings enhancing) this year itself,” he adds. 

“Cipla has been our top picks since long. We have a price target of around Rs 462 per share for Cipla. If the investor holds on to Cipla it will be a good strategy and the investor can book profits around Rs 450-460," he says.

Set email alert for

ADS BY GOOGLE

video of the day

Barring IT & pharma, Q2 earnings to disappoint: Dimensions

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.